{
}
UBS has maintained a "Buy" rating for Wacker Chemie, setting a target price of EUR 102. Despite a slightly better operating result (EBITDA), free cash flow fell significantly short of expectations, leading to anticipated negative price reactions at the market's opening.
UBS has maintained a 'Buy' rating for Wacker Chemie, setting a target price of 102 euros. While the company's operating result (EBITDA) exceeded expectations, free cash flow fell significantly short, leading analysts to anticipate a slight negative market reaction at the start of trading.
Wacker Chemie AG, a German specialty chemicals manufacturer, operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. The Silicones segment offers a variety of products including silanes and elastomers, while Polymers provides polymer binders and additives. The Biosolutions segment caters to food and pharmaceutical industries, and the Polysilicon segment produces high-purity polysilicon for solar technology and semiconductors.
UBS has maintained a "Buy" rating for Wacker Chemie while reducing its price target from EUR 110 to EUR 102. Analyst Geoff Haire anticipates fourth-quarter operating earnings (EBITDA) to be 8% below consensus, as noted in his outlook ahead of the March 12 report.
UBS has reduced its price target for Wacker Chemie from €110 to €102 while maintaining a "Buy" rating. Analyst Geoff Haire anticipates fourth-quarter operating earnings (EBITDA) to be 8% below consensus, as noted in his outlook ahead of the report scheduled for March 12. As of December 18, Wacker Chemie's stock is trading at €68.50, reflecting a decline of 1.18%.
UBS has maintained a "Buy" rating for Wacker Chemie with a target price of 110 euros. Analyst Geoff Haire highlighted that a potential ceasefire between Russia and Ukraine could lead to increased gas exports to Europe, significantly lowering gas prices and benefiting companies like BASF, Covestro, and Lanxess.
The global pharmaceutical excipients market is projected to grow from $9.56 billion in 2023 to $18.01 billion by 2033, with a CAGR of 6.54%. Binders are the leading segment, enhancing drug formulation, while Asia-Pacific is expected to dominate market share due to cost advantages and rising healthcare demands. Europe will experience the fastest growth, driven by the influx of large pharmaceutical companies and the increasing need for innovative excipients.
UBS has maintained a 'Buy' rating for Wacker Chemie, setting a target price of 110 euros. Analyst Geoff Haire noted that the company's operating result (EBITDA) fell 7 percent short of consensus expectations, with the midpoint of the annual target range also disappointing and cash inflow weaker than anticipated.
UBS has rated Wacker Chemie as a 'Buy' with a target price of 110 euros. The stock closed at 82.70 euros, reflecting a decline of 2.71% on the previous day. The annual high for the stock is 125.80 euros, while the low stands at 77.52 euros.
UBS has maintained its "Buy" rating for Wacker Chemie, setting a target price of 110 euros. Analyst Geoff Haire noted that the company's operating result (EBITDA) fell 7 percent short of consensus expectations, with the midpoint of the annual target range also below forecasts and weaker cash inflow reported.
Wacker Chemie AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for wacker chemie with target price of 102 euro
11:19 28.01.2025
ubs maintains buy rating for wacker chemie despite mixed financial results
11:05 28.01.2025
Wacker Chemie AG maintains strong market position in specialty chemicals sector
10:54 28.01.2025
UBS Maintains Buy Rating for Wacker Chemie Despite Lowered Price Target
11:00 18.12.2024
UBS Lowers Wacker Chemie Price Target to 102 Euros While Maintaining Buy Rating
10:38 18.12.2024
UBS Maintains Buy Rating for Wacker Chemie with Target Price of 110 Euros
13:56 09.12.2024
global pharmaceutical excipients market projected to reach 18 billion by 2033
United States Dollar
Lubrizol Company
Ashland Inc.
Eastman Chemical Company
Signet Chemical Corporation Pvt. Ltd
Vertiv Holdings Co
Dow Chemical Co.
Valeant Pharmaceuticals International CORPORATION
FMC Company
Solutions Univar Inc.
Wacker Chemie AG
Evonik Industries AG
P&G Chemicals
Roquette Group
Finar Limited
ZAF
FRA
ITA
CHN
CAN
DEU
ESP
ARE
MEX
USA
BRA
JPN
GBR
IND
Show more
13:45 08.11.2024
ubs maintains buy rating for wacker chemie with target price of 110 euros
10:32 28.10.2024
ubs rates wacker chemie a buy with target price of 110 euros
09:45 28.10.2024
ubs maintains buy rating for wacker chemie with target price of 110 euros
09:45 28.10.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Finance Mergers & Acquisitions
Hedge Funds & Private Equity
Global Trade Developments
Global Financial Events
Market Analysis and Predictions
Financial Scams and Security
Government Policies
Banking Regulations
CEO Changes
Startups & Entrepreneurship
Economic Sanctions
Retail and Consumer Goods
Industry Mergers & Acquisitions
Central Bank Actions
Workplace Trends
International Relations
Government Economic Policies
Countries:
Companies:
JPMorgan Chase & Co.
Tesla, Inc.
The Goldman Sachs Group, Inc.
Wells Fargo & Company
Apple Inc.
Bank of America Corporation
Barclays PLC
Citigroup Inc.
Morgan Stanley
Berkshire Hathaway Inc.
Microsoft Corporation
SpaceXCoin USD
The Charles Schwab Corporation
AMERICAN EXPRESS
Amazon.com, Inc.
U.S. Bancorp
UBS Group AG
Banco Santander, S.A.
Deutsche Bank Money Market PP
Citizens, Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
British Pound Sterling
South Korean Won
Swiss Franc
United Arab Emirates Dirham
Canadian Dollar
Israeli New Shekel
Swedish Krona
Mexican Peso
New Taiwan Dollar
Egyptian Pound
People: